China Medical GatewayLoading your healthcare gateway…

Zhao De Ping

Zhao De Ping — Chief Physician — Thoracic Surgery — Shanghai Pulmonary Hospital

Specialties

Single-port thoracoscopy and single-port robot-assisted surgery are used to treat various lung diseases such as lung cancer, lung nodules, and mediastinal tumors. Mediastinal tumors are primarily treated with surgery as part of a comprehensive treatment. Lung transplantation surgery is used to treat end-stage lung disease.

Education

Doctor of Medicine, from July 2006 to September 2007, studied thoracic surgery techniques such as thoracoscopic surgery at the Mayo Clinic Medical Center and Memorial Sloan-Kettering Cancer Center in the United States.

Professional Experience

Doctor of Medicine, Chief Thoracic Surgeon, Associate Professor, PhD Supervisor, Postdoctoral Co-supervisor. Administrative Director of the Department of Thoracic Surgery at Shanghai Pulmonary Hospital affiliated with Tongji University, Executive Director of the Lung Transplantation Center, Head of the Robotic and Mediastinal Disease Subspecialty. Recognized as a Shanghai Medical Artisan, Leader of the Thoracic Surgery Specialty Alliance at Shanghai Municipal Hospitals. From July 2006 to September 2007, studied thoracic surgery techniques such as thoracoscopic surgery at the Mayo Clinic Medical Center and Memorial Sloan-Kettering Cancer Center in the United States. In 2011, received the nomination award of the Silver Snake Award, the highest honor for young talents in the Shanghai health system. In 2015, won the only top award – the Excellence Award – in the AME-Medtronic National Thoracoscopic Pulmonary Resection Surgery Video Competition. Since 1997, has worked in the Department of Thoracic Surgery at Shanghai Pulmonary Hospital, engaging in clinical thoracic surgery work for over 29 years, performing nearly 2,000 surgeries per year personally. Specializes in robotic and single-port as well as subxiphoid single-port thoracoscopic treatment of early-stage lung cancer and various lung diseases, mediastinal tumors, etc. In 2013, was one of the earliest experts in China to perform single-port thoracoscopic lobectomy surgeries. In 2014, carried out the first subxiphoid single-port thoracoscopic lobectomy in China, with related surgical experience and videos presented multiple times at international and domestic conferences as surgical demonstrations. In February 2021, performed the world's first single-operator port robotic lobar sleeve resection. Since 2022, has been one of the earliest in the world to conduct large-scale robotic single-port lung resection surgeries, personally completing over 1,200 cases, ranking first globally. Robotic surgery, with its three-dimensional view and higher magnification, provides a clearer view than conventional thoracoscopy; the flexible operating arms can rotate up to 270 degrees, far beyond human hands, and can filter hand tremors. It is especially suitable for complex lung and mediastinal tumor surgeries, offering lower surgical risks and more thorough lymph node dissection.

Professional Roles

Member and Secretary of the Thoracic Surgery Branch of the Shanghai Medical Association; Member and Secretary of the Thoracic Surgery Physicians Branch of the Shanghai Medical Doctors Association; Head of the Minimally Invasive Surgery Group; Standing Committee Member of the Lung Cancer Committee of the Wu Jieping Medical Foundation; Member of the Mediastinal Tumor Professional Committee of the Chinese Anti-Cancer Association; Standing Committee Member of the Integrated Rehabilitation Professional Committee for Pulmonary Tumors of the Chinese Anti-Cancer Association; Standing Committee Member of the Integrated Rehabilitation Professional Committee for Mediastinal Tumors of the Chinese Anti-Cancer Association; Standing Committee Member of the Minimally Invasive Treatment of Thoracic Tumors Professional Committee of the Chinese Association of Medical Education; Member of the Thoracic Surgery Branch of the China Research Hospital Association; Member of the Thoracic Surgery Branch of the Chinese Association of Medical Education; Deputy Editor-in-Chief of Thoracic Cancer

Return to Home